Press Releases
May 2, 2006
Debiopharm et la Haute Ecole Valaisanne collaborent pour développer les médicaments de demain
April 25, 2006
Debiopharm presents phase I monthly implant and phase II daily oral results of ZT-1 for Alzheimer´s disease
February 9, 2006
Debiopharm S.A. presented results of a double-blind placebo-controlled study on first-in-class Debio-025 in HIV-1-infected subjects
December 20, 2005
Debiopharm and Dyax Corp. restructure development agreement for Depelestat (EPI-hNE4 or DX-890) in pulmonary disorders
September 20, 2005
The Japanese Cancer Association (JCA) and Debiopharm present the inaugural 2005 JCA-Mauvernay award in Japan
September 15, 2005
Debiovision Inc., a speciality pharmaceutical developer joins the Debio companies
June 27, 2005
Debiopharm and Neovacs sign License and Equity Agreement for the development fo Neovacs´ anti-TNF-Alpha product